AI Insight
A clinical trial presented at the European Respiratory Society Congress demonstrates that laughter therapy can reduce breathing difficulties in patients with chronic obstructive pulmonary disease (COPD). The study found that laughter therapy was equally effective as traditional breathing exercises in improving respiratory symptoms for this patient population.
Why it matters
This research suggests that laughter therapy could serve as an alternative or complementary treatment option for COPD patients who struggle with conventional breathing exercises. The findings may expand therapeutic options for managing this chronic respiratory condition, potentially improving patient adherence and quality of life.
Understand the Science
A clinical trial for patients with chronic obstructive pulmonary disease (COPD) shows that laughter therapy can reduce breathing difficulties and is as effective as more traditional breathing exercises. The research was presented at the European Respiratory Society (ERS) Congress in Barcelona, Spain.
Source: Laughter therapy can help people with COPD breathe more easily